Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?

Detalles Bibliográficos
Autores principales: Honore, Patrick M., De Bels, David, Redant, Sebastien, Spapen, Herbert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408561/
https://www.ncbi.nlm.nih.gov/pubmed/30850912
http://dx.doi.org/10.1186/s13613-019-0512-0
_version_ 1783401791720783872
author Honore, Patrick M.
De Bels, David
Redant, Sebastien
Spapen, Herbert D.
author_facet Honore, Patrick M.
De Bels, David
Redant, Sebastien
Spapen, Herbert D.
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-6408561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-64085612019-03-27 Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration? Honore, Patrick M. De Bels, David Redant, Sebastien Spapen, Herbert D. Ann Intensive Care Editorial Springer International Publishing 2019-03-08 /pmc/articles/PMC6408561/ /pubmed/30850912 http://dx.doi.org/10.1186/s13613-019-0512-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Editorial
Honore, Patrick M.
De Bels, David
Redant, Sebastien
Spapen, Herbert D.
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
title Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
title_full Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
title_fullStr Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
title_full_unstemmed Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
title_short Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
title_sort eliminating endotoxin by polymyxin b hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408561/
https://www.ncbi.nlm.nih.gov/pubmed/30850912
http://dx.doi.org/10.1186/s13613-019-0512-0
work_keys_str_mv AT honorepatrickm eliminatingendotoxinbypolymyxinbhemoperfusionandorcontinuousrenalreplacementtherapyshouldthefocusbeontimingdosingandtypeofrenalepuration
AT debelsdavid eliminatingendotoxinbypolymyxinbhemoperfusionandorcontinuousrenalreplacementtherapyshouldthefocusbeontimingdosingandtypeofrenalepuration
AT redantsebastien eliminatingendotoxinbypolymyxinbhemoperfusionandorcontinuousrenalreplacementtherapyshouldthefocusbeontimingdosingandtypeofrenalepuration
AT spapenherbertd eliminatingendotoxinbypolymyxinbhemoperfusionandorcontinuousrenalreplacementtherapyshouldthefocusbeontimingdosingandtypeofrenalepuration

Ejemplares similares